Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.43 |
| ▸ | PPARA | Q07869 | 8/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12825608 | 0.91 | PPARG (0.40) | PPARGPPARAALOX15NPSR1L3MBTL1 | |
| SCHEMBL5523869 | 0.85 | PPARG (0.41) | PPARGPPARAALOX15NPSR1L3MBTL1 | |
| SCHEMBL29268253 | 0.82 | ADORA3 (0.38) | PPARGPPARAL3MBTL1MAPTADORA3 | |
| SCHEMBL5514895 | 0.82 | PPARG (0.43) | PPARGPPARAL3MBTL1MAPTKMT2A | |
| SCHEMBL5515484 | 0.80 | PPARG (0.38) | PPARGPPARAALOX15NPSR1L3MBTL1 | |
| SCHEMBL5508342 | 0.80 | PPARA (0.46) | PPARGPPARACYP3A4 | |
| SCHEMBL23754112 | 0.80 | PPARG (0.45) | PPARGPPARAALOX15NPSR1L3MBTL1 | |
| SCHEMBL8356600 | 0.80 | KMT2A (0.43) | NPSR1L3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL28049678 | 0.79 | PPARG (0.48) | PPARGPPARAALDH1A1 | |
| SCHEMBL4756797 | 0.79 | PPARG (0.48) | PPARGPPARAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739303-B1 | A NOVEL METHOD FOR PERORAL DELIVERY OF INSULIN AND ITS ANALOGUES FOR THERAPEUTIC USAGE | TRANSGENE BIOTEK LTD (IN) | 2020-04-01 | — | — | EP | claimed |
| US-20150051142-A1 | NOVEL METHOD FOR PERORAL DELIVERY OF INSULIN AND ITS ANALOGUES FOR THERAPEUTIC USAGE | TRANSGENE BIOTEK LTD (IN) | 2015-02-19 | — | — | US | claimed |
| EP-2739303-A2 | A NOVEL METHOD FOR PERORAL DELIVERY OF INSULIN AND ITS ANALOGUES FOR THERAPEUTIC USAGE | Transgene Biotek Ltd. (IN) | 2014-06-11 | — | — | EP | claimed |
| WO-2013021346-A2 | A NOVEL METHOD FOR PERORAL DELIVERY OF INSULIN AND ITS ANALOGUES FOR THERAPEUTIC USAGE | TRANSGENE BIOTEK LTD (IN) | 2013-02-14 | — | — | WO | claimed |
| EP-4729131-A2 | METHODS FOR FIXING HAIR AND SKIN | Olaplex, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260090991-A1 | COMPOSITIONS AND METHODS OF DELIVERING LARGE PROTEINS | UNIV BROWN (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260021028-A1 | Formulations, Kits, and Methods of Use Thereof for Coils, Curls, and Waves in Hair | OLAPLEX INC (US) | 2026-01-22 | — | — | US | disclosed |
| US-20260000626-A1 | POLYMERIC NANOPARTICLES FOR LONG ACTING DELIVERY OF A PEPTIDE AND METHODS OF MAKING AND USING THEREOF | UNIV BROWN (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250381425-A1 | METHODS FOR FIXING HAIR AND SKIN | OLAPLEX INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250302704-A1 | METHODS FOR FIXING HAIR AND SKIN | GOLDMAN SACHS BANK USA | 2025-10-02 | — | — | US | disclosed |
| US-20250281624-A1 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES | UNIVERSITY OF HOUSTON SYSTEM (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4561640-A1 | METHODS FOR DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION | The Methodist Hospital (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-0476045-B1 | BIOERODIBLE POLYMERS FOR DRUG DELIVERY IN BONE | MASSACHUSETTS INST TECHNOLOGY (US) | 1996-08-28 | — | — | EP | disclosed |
| WO-1996011671-A1 | TARGETED DELIVERY VIA BIODEGRADABLE POLYMERS | FOCAL, INC. (US) | 1996-04-25 | — | — | WO | disclosed |
| EP-0671906-A1 | BIOADHESIVE MICROSPHERES AND THEIR USE AS DRUG DELIVERY AND IMAGING SYSTEMS | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 1995-09-20 | — | — | EP | disclosed |
| WO-1993021906-A9 | BIOADHESIVE MICROSPHERES AND THEIR USE AS DRUG DELIVERY AND IMAGING SYSTEMS | — | 1994-03-17 | — | — | WO | disclosed |
| US-5286763-A | Polyanhydride and biacative molecular; nontoxic residues | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1994-02-15 | — | — | US | disclosed |
| WO-1993021906-A1 | BIOADHESIVE MICROSPHERES AND THEIR USE AS DRUG DELIVERY AND IMAGING SYSTEMS | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 1993-11-11 | — | — | WO | disclosed |
| EP-0476045-A1 | BIOERODIBLE POLYMERS FOR DRUG DELIVERY IN BONE. | MASSACHUSETTS INST TECHNOLOGY (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1990015586-A2 | BIOERODIBLE POLYMERS FOR DRUG DELIVERY IN BONE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302704-A1 | METHODS FOR FIXING HAIR AND SKIN | KRT18, CUTA, COL14A1 | PPARG 3546/4885PPARA 3797/4885ALOX15 4702/4885 |
| US-20260090991-A1 | COMPOSITIONS AND METHODS OF DELIVERING LARGE PROTEINS | FCGRT, CD63, FCGR3B | PPARG 3877/4885PPARA 3885/4885ALOX15 636/4885 |
| US-20260000626-A1 | POLYMERIC NANOPARTICLES FOR LONG ACTING DELIVERY OF A PEPTIDE AND METHODS OF MAKING AND USING THEREOF | VEGFA, IAPP, NPPA | PPARG 4472/4885PPARA 4345/4885ALOX15 4758/4885 |
| US-20250281624-A1 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES | FABP2, MYADM, FABP6 | PPARG 137/4885PPARA 630/4885ALOX15 689/4885 |
| US-20250381425-A1 | METHODS FOR FIXING HAIR AND SKIN | CUTA, SUCLG1, TST | PPARG 3816/4885PPARA 3708/4885ALOX15 1762/4885 |
| US-20260021028-A1 | Formulations, Kits, and Methods of Use Thereof for Coils, Curls, and Waves in Hair | DNMT3L, KRT18, INHA | PPARG 4547/4885PPARA 4050/4885ALOX15 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.